Grace Therapeutics, Inc. - GRCE
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 20
Latest filed: Sep 10, 2026
| Form | Count |
|---|---|
| 8-K | 8 |
| 4 | 7 |
| SCHEDULE 13G/A | 4 |
| SCHEDULE 13G | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Sep 10, 2026 | 4 | Sep 08, 2026 | 0001493152-26-042152 | View |
| Sep 10, 2026 | 4 | Sep 09, 2026 | 0001140361-26-036125 | View |
| Sep 01, 2026 | 4 | Aug 28, 2026 | 0001140361-26-035318 | View |
| Sep 01, 2026 | 4 | Aug 28, 2026 | 0001140361-26-035319 | View |
| Sep 01, 2026 | 4 | Aug 28, 2026 | 0001140361-26-035317 | View |
| Sep 01, 2026 | 4 | Aug 28, 2026 | 0001140361-26-035316 | View |
| Aug 19, 2026 | 4 | Aug 14, 2026 | 0001493152-26-039124 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | — | 0001104659-26-097338 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | — | 0001104659-26-097290 | View |
| Aug 13, 2026 | 8-K | Aug 13, 2026 | 0001140361-26-032644 | View |
| Aug 07, 2026 | SCHEDULE 13G | — | 0001493152-26-036565 | View |
| Aug 06, 2026 | 8-K | Aug 04, 2026 | 0001140361-26-031671 | View |
| Jul 28, 2026 | 8-K | Jul 28, 2026 | 0001140361-26-029837 | View |
| Jun 18, 2026 | 8-K | Jun 18, 2026 | 0001140361-26-025667 | View |
| Jun 18, 2026 | 8-K | Jun 18, 2026 | 0001140361-26-025669 | View |
| Jun 05, 2026 | 8-K | Jun 01, 2026 | 0001140361-26-024269 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0001104659-26-062871 | View |
| Apr 27, 2026 | 8-K | Apr 27, 2026 | 0001140361-26-016834 | View |
| Apr 27, 2026 | SCHEDULE 13G/A | — | 0001493152-26-019071 | View |
| Apr 23, 2026 | 8-K | Apr 23, 2026 | 0001140361-26-016324 | View |